Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Tofacitinib may help treat severe hair loss, but more research is needed.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Mitf plays a key role in melanoma progression and is linked to disease stage.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.